The Pennant Group (PNTG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Werte in diesem Artikel
For the quarter ended September 2025, The Pennant Group, Inc. (PNTG) reported revenue of $229.04 million, up 26.8% over the same period last year. EPS came in at $0.30, compared to $0.26 in the year-ago quarter.The reported revenue represents a surprise of +2.71% over the Zacks Consensus Estimate of $223 million. With the consensus EPS estimate being $0.29, the EPS surprise was +3.45%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how The Pennant Group performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenue- Total home health and hospice services: $173.57 million versus $169.41 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +27.9% change.Revenue- Senior living services: $55.47 million compared to the $54.57 million average estimate based on two analysts. The reported number represents a change of +23.2% year over year.Revenue- Home health and hospice services- Home care and other: $15.69 million versus $13.51 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +31.5% change.Revenue- Home health and hospice services- Hospice: $76.38 million versus $74.78 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +21.7% change.Revenue- Home health and hospice services- Home health: $81.5 million versus $81.12 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +33.6% change.View all Key Company Metrics for The Pennant Group here>>>Shares of The Pennant Group have returned +1.1% over the past month versus the Zacks S&P 500 composite's +1% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks Names #1 Semiconductor StockThis under-the-radar company specializes in semiconductor products that titans like NVIDIA don't build. It's uniquely positioned to take advantage of the next growth stage of this market. And it's just beginning to enter the spotlight, which is exactly where you want to be.With strong earnings growth and an expanding customer base, it's positioned to feed the rampant demand for Artificial Intelligence, Machine Learning, and Internet of Things. Global semiconductor manufacturing is projected to explode from $452 billion in 2021 to $971 billion by 2028.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Pennant Group, Inc. (PNTG): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Übrigens: Pennant Group und andere US-Aktien sind bei finanzen.net ZERO sogar bis 23 Uhr handelbar (ohne Ordergebühren, zzgl. Spreads). Jetzt kostenlos Depot eröffnen und Neukunden-Bonus sichern!
Ausgewählte Hebelprodukte auf Pennant Group
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Pennant Group
Der Hebel muss zwischen 2 und 20 liegen
| Name | Hebel | KO | Emittent |
|---|
| Name | Hebel | KO | Emittent |
|---|
Quelle: Zacks
Nachrichten zu Pennant Group Inc Registered Shs When Issued
Analysen zu Pennant Group Inc Registered Shs When Issued
Keine Analysen gefunden.